Testosterone treatment and mortality in men with low testosterone levels - PubMed (original) (raw)
Testosterone treatment and mortality in men with low testosterone levels
Molly M Shores et al. J Clin Endocrinol Metab. 2012 Jun.
Abstract
Context: Low testosterone levels in men have been associated with increased mortality. However, the influence of testosterone treatment on mortality in men with low testosterone levels is not known.
Objective: The objective of the study was to examine the association between testosterone treatment and mortality in men with low testosterone levels.
Design: This was an observational study of mortality in testosterone-treated compared with untreated men, assessed with time-varying, adjusted Cox proportional hazards regression models. Effect modification by age, diabetes, and coronary heart disease was tested a priori.
Setting: The study was conducted with a clinical database that included seven Northwest Veterans Affairs medical centers.
Patients: Patients included a cohort of 1031 male veterans, aged older than 40 yr, with low total testosterone [≤250 ng/dl (8.7 nmol/liter)] and no history of prostate cancer, assessed between January 2001 and December 2002 and followed up through the end of 2005.
Main outcome measure: Total mortality in testosterone-treated compared with untreated men was measured.
Results: Testosterone treatment was initiated in 398 men (39%) during routine clinical care. The mortality in testosterone-treated men was 10.3% compared with 20.7% in untreated men (P<0.0001) with a mortality rate of 3.4 deaths per 100 person-years for testosterone-treated men and 5.7 deaths per 100 person-years in men not treated with testosterone. After multivariable adjustment including age, body mass index, testosterone level, medical morbidity, diabetes, and coronary heart disease, testosterone treatment was associated with decreased risk of death (hazard ratio 0.61; 95% confidence interval 0.42-0.88; P = 0.008). No significant effect modification was found by age, diabetes, or coronary heart disease.
Conclusions: In an observational cohort of men with low testosterone levels, testosterone treatment was associated with decreased mortality compared with no testosterone treatment. These results should be interpreted cautiously because residual confounding may still be a source of bias. Large, randomized clinical trials are needed to better characterize the health effects of testosterone treatment in older men with low testosterone levels.
Comment in
- Caveat emptor: does testosterone treatment reduce mortality in men?
Wu FC. Wu FC. J Clin Endocrinol Metab. 2012 Jun;97(6):1884-6. doi: 10.1210/jc.2012-1977. J Clin Endocrinol Metab. 2012. PMID: 22675063 No abstract available. - Testosterone therapy and mortality in US veterans.
Yeap BB. Yeap BB. Asian J Androl. 2012 Sep;14(5):667-8. doi: 10.1038/aja.2012.74. Epub 2012 Jul 23. Asian J Androl. 2012. PMID: 22820856 Free PMC article. No abstract available.
Similar articles
- Low serum testosterone and mortality in male veterans.
Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Shores MM, et al. Arch Intern Med. 2006 Aug 14-28;166(15):1660-5. doi: 10.1001/archinte.166.15.1660. Arch Intern Med. 2006. PMID: 16908801 - Increased incidence of diagnosed depressive illness in hypogonadal older men.
Shores MM, Sloan KL, Matsumoto AM, Moceri VM, Felker B, Kivlahan DR. Shores MM, et al. Arch Gen Psychiatry. 2004 Feb;61(2):162-7. doi: 10.1001/archpsyc.61.2.162. Arch Gen Psychiatry. 2004. PMID: 14757592 - Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
Muraleedharan V, Marsh H, Kapoor D, Channer KS, Jones TH. Muraleedharan V, et al. Eur J Endocrinol. 2013 Oct 21;169(6):725-33. doi: 10.1530/EJE-13-0321. Print 2013 Dec. Eur J Endocrinol. 2013. PMID: 23999642 Clinical Trial. - Low testosterone in men with type 2 diabetes: significance and treatment.
Grossmann M. Grossmann M. J Clin Endocrinol Metab. 2011 Aug;96(8):2341-53. doi: 10.1210/jc.2011-0118. Epub 2011 Jun 6. J Clin Endocrinol Metab. 2011. PMID: 21646372 Review. - Controversies and Advances With Testosterone Therapy: A 40-Year Perspective.
Morgentaler A. Morgentaler A. Urology. 2016 Mar;89:27-32. doi: 10.1016/j.urology.2015.11.034. Epub 2015 Dec 9. Urology. 2016. PMID: 26683750 Review.
Cited by
- Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence.
Cheung KK, Luk AO, So WY, Ma RC, Kong AP, Chow FC, Chan JC. Cheung KK, et al. J Diabetes Investig. 2015 Mar;6(2):112-23. doi: 10.1111/jdi.12288. Epub 2014 Nov 3. J Diabetes Investig. 2015. PMID: 25802717 Free PMC article. Review. - Type 2 Diabetes and Testosterone Therapy.
Hackett G. Hackett G. World J Mens Health. 2019 Jan;37(1):31-44. doi: 10.5534/wjmh.180027. Epub 2018 Jul 17. World J Mens Health. 2019. PMID: 30079639 Free PMC article. Review. - Andrology: Testosterone and cardiovascular risk--deciphering the statistics.
Morgentaler A, Kacker R. Morgentaler A, et al. Nat Rev Urol. 2014 Mar;11(3):131-2. doi: 10.1038/nrurol.2014.24. Epub 2014 Feb 18. Nat Rev Urol. 2014. PMID: 24535586 No abstract available. - Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.
Traish AM, Haider A, Doros G, Saad F. Traish AM, et al. Int J Clin Pract. 2014 Mar;68(3):314-29. doi: 10.1111/ijcp.12319. Epub 2013 Oct 15. Int J Clin Pract. 2014. PMID: 24127736 Free PMC article. - Controversies in testosterone replacement therapy: testosterone and cardiovascular disease.
Hwang K, Miner M. Hwang K, et al. Asian J Androl. 2015 Mar-Apr;17(2):187-91. doi: 10.4103/1008-682X.146968. Asian J Androl. 2015. PMID: 25652628 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical